RDDT partners with community based provider health organizations (400k patient lives and up) to commercialize their de-identified healthcare data for the purpose of conducting compliant commercially sponsored (by bio-pharma) targeted searches for undiagnosed lost rare and ultra rare disease patients. Bringing an end to the typical and painful rare disease diagnostic odyssey, for the benefit of the patient.